Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Syndax Pharmaceuticals, Inc. | StockGist | StockGist

Companies
SNDX
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings SNDXSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Syndax Pharmaceuticals, Inc.

Filed Feb 9, 2026

Accepted Feb 9, 2026, 12:00 AM ET

CIK 0001395937

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Syndax Pharmaceuticals Inc

Person Type

HC

CUSIP: 87164F105

Amendment History

9 filings

SCHEDULE 13G
Original
Viewing
Feb 9, 20260000093751-26-000090
SCHEDULE 13G/A
Amendment 1
Feb 14, 20250001085146-25-001726
SCHEDULE 13G/A
Amendment 2
Mar 7, 20250000902219-25-000138
SCHEDULE 13G/A
Amendment 3
Apr 17, 20250001576419-25-000656
SCHEDULE 13G/A
Amendment 4
May 7, 20250000895421-25-000369
SCHEDULE 13G/A
Amendment 5
May 9, 20250000769993-25-000250
SCHEDULE 13G/A
Amendment 6
Aug 13, 20250000769993-25-000479
SCHEDULE 13G/A
Amendment 7
Aug 14, 20250000902664-25-003706
SCHEDULE 13G/A
Amendment 8
Latest
Jan 30, 20260000102909-26-000252

Recent Filings

Syndax Pharmaceuticals, Inc.1 months ago

Syndax Pharmaceuticals, Inc.1 months ago

Syndax Pharmaceuticals, Inc.2 months ago

Syndax Pharmaceuticals, Inc.2 months ago

Syndax Pharmaceuticals, Inc.3 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice